Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZR-02-01 in osteoarthritis pain
NCT00108771Phase 2Completed
- Sponsor
- ZARS Pharmaceuticals
- Start
- Apr 2004
- Primary completion
- Sep 2006
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing ZR-02-01 with Placebo (2 arms). Primary endpoint: WOMAC Knee and Hip Osteoarthritis Index at 12 weeks. Started Apr 2004; status: completed.
02
Drugs
ZR-02-01
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00108771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108771.